Introduction: Ambulatory 24-hour esophageal pH monitoring, considered the gold standard for the diagnosis of gastroesophageal reflux disease, is currently performed using an indwelling esophageal catheter passed through the nose. Patient complaints of nasal and pharyngeal discomfort, rhinorrhea, and social embarrassment are common. The TM pH system avoids such discomfort by using a catheter-free capsule temporarily attached to the esophageal mucosa. Data is transmitted.via radiofrequency to a receiver. The study evaluated the efficacy of the TM system in measuring esophageal pH. Methods: Seven asymptomatic subjects were randomized to receive either a TM probe only, or a TM probe and a conventional pH catheter. Each was positioned 5cm proximal to the manometrically determined upper border of the lower esophageal sphincter. Those subjects receiving both a TM probe and a conventional catheter were monitored for a comparable period. The detection of reflux characteristics was compared. Results: In 7 subjects signal reception was maintained at a median level of 88.4% for a median monitoring period of 47 hours. A chest x-ray demonstrated that all TM probes had detached from the esophagus by day 10. In 4 subjects who also had a pH catheter for the first 24 hours similar results by both techniques were demonstrated (Table). Discussion: The BRAVO probe is comparable to the conventional catheter for quantifying esophageal pH. The greater comfort of the TM catheter-free system may lead to increased patient acceptance and compliance of this clinical test for gastroesophageal reflux disease.